HOLOGRAPHIC GENOME SEQUENCING
DEAD

Serial Number

90002945

Owner

Carl Raymond Amos

Filing Date

Jun 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HOLOGRAPHIC GENOME SEQUENCING Trademark

Serial Number: 90002945

HOLOGRAPHIC GENOME SEQUENCING is a trademark filed by Carl Raymond Amos on June 15, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Carl Raymond Amos (6 trademarks)

8710 W. Hillsborough Ave #413
Tampa, FL 33615

Entity Type: 01

Trademark Details

Filing Date

June 15, 2020

Registration Date

Not Registered

Goods & Services

DNA analysis services for scientific research purposes; DNA analysis services to determine paternity; DNA screening for scientific research purposes; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Genome amplification; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Drug, alcohol and DNA screening for forensic research purposes; Providing information in the field of plant genetics research resources; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing scientific research information in the field of genetics; Providing scientific research information in the field of genomics; Providing scientific research information in the field of holographic genome sequencing; Providing scientific research information in the field of holographic genome testing; Providing scientific research information in the field of gene splicing; Providing scientific research information in the field of holographic gene splicing; Providing scientific research information in the field of decoding genes; Providing scientific research information in the field of decoding genomes; Providing scientific research information in the field of decoding DNA; Providing scientific research information in the field of holographic genome decoding; Providing scientific research information in the field of holographic genomic decoding; Providing scientific research information in the field of genome decoding holography; Scientific research consulting in the field of genetics; Scientific research consulting in the field of genomics; Scientific research consulting in the field of holographic genome sequencing; Scientific research consulting in the field of holographic genome testing; Scientific research consulting in the field of gene splicing; Scientific research consulting in the field of holographic gene splicing; Scientific research consulting in the field of decoding genes; Scientific research consulting in the field of decoding genomes; Scientific research consulting in the field of decoding DNA; Scientific research consulting in the field of holographic genome decoding; Scientific research consulting in the field of holographic genomic decoding; Scientific research consulting in the field of genome decoding holography; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of genetics; Scientific research in the field of genomics; Scientific research in the field of holographic genome sequencing; Scientific research in the field of holographic genome testing; Scientific research in the field of gene splicing; Scientific research in the field of holographic gene splicing; Scientific research in the field of decoding genes; Scientific research in the field of decoding genomes; Scientific research in the field of decoding DNA; Scientific research in the field of holographic genome decoding; Scientific research in the field of holographic genomic decoding; Scientific research in the field of genome decoding holography; Structural and functional analysis of genomes; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Apr 26, 2021 MAB1
ABANDONMENT - EXPRESS MAILED
Apr 26, 2021 ABN1
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 13, 2020 NWOS
NEW APPLICATION ENTERED
Jun 18, 2020 NWAP